EA027609B8 - Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfa - Google Patents

Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfa

Info

Publication number
EA027609B8
EA027609B8 EA201500385A EA201500385A EA027609B8 EA 027609 B8 EA027609 B8 EA 027609B8 EA 201500385 A EA201500385 A EA 201500385A EA 201500385 A EA201500385 A EA 201500385A EA 027609 B8 EA027609 B8 EA 027609B8
Authority
EA
Eurasian Patent Office
Prior art keywords
alfa
interferon beta
pharmaceutical composition
producing
injection
Prior art date
Application number
EA201500385A
Other languages
Russian (ru)
Other versions
EA027609B9 (en
EA027609B1 (en
EA201500385A1 (en
Inventor
Фернандо Прочаска
Эдгардо Кастанья
Эрнан Гомес
Original Assignee
Тютор С.А.С.И.Ф.И.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тютор С.А.С.И.Ф.И.А. filed Critical Тютор С.А.С.И.Ф.И.А.
Priority to EA201500385A priority Critical patent/EA027609B9/en
Publication of EA201500385A1 publication Critical patent/EA201500385A1/en
Publication of EA027609B1 publication Critical patent/EA027609B1/en
Publication of EA027609B8 publication Critical patent/EA027609B8/en
Publication of EA027609B9 publication Critical patent/EA027609B9/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Provided is a method of producing a pharmaceutical composition comprising interferon beta-1α as an active ingredient in the form of a solution for injection. Preferably the solution for injection is used as a pre-filled syringe. The proposed method provides producing a pharmaceutical composition with high content of stability with regard to biological activity.
EA201500385A 2015-04-29 2015-04-29 Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfa EA027609B9 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201500385A EA027609B9 (en) 2015-04-29 2015-04-29 Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201500385A EA027609B9 (en) 2015-04-29 2015-04-29 Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfa

Publications (4)

Publication Number Publication Date
EA201500385A1 EA201500385A1 (en) 2016-10-31
EA027609B1 EA027609B1 (en) 2017-08-31
EA027609B8 true EA027609B8 (en) 2017-10-31
EA027609B9 EA027609B9 (en) 2017-11-30

Family

ID=57189636

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201500385A EA027609B9 (en) 2015-04-29 2015-04-29 Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfa

Country Status (1)

Country Link
EA (1) EA027609B9 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100524872B1 (en) * 2003-12-04 2005-11-01 씨제이 주식회사 Processes for the purification of interferon beta
US20080219952A1 (en) * 2005-08-26 2008-09-11 Ares Trading S.A. Process For the Preparation of Glycosylated Interferon Beta
CN102219848B (en) * 2011-05-25 2014-01-22 浙江海正药业股份有限公司 Purification method for recombinant human interferon beta-1a

Also Published As

Publication number Publication date
EA027609B9 (en) 2017-11-30
EA027609B1 (en) 2017-08-31
EA201500385A1 (en) 2016-10-31

Similar Documents

Publication Publication Date Title
ZA202102906B (en) Liquid protein formulations containing viscosity-lowering agents
SG10201902915VA (en) Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
PH12018500690A1 (en) Novel insulin analogs and use thereof
JOP20200109A1 (en) Injectable preparation
UA116060C2 (en) Process for manufacturing glatiramer acetate product
PH12019501363A1 (en) Insulin containing pharmaceutical compositions
MX2021003908A (en) Long-acting polypeptides and methods of producing and administering same.
MX2020008129A (en) Pharmaceutical composition comprising acylated derivative of human insulin analog and preparation method thereof.
EA027609B9 (en) Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfa
MX2020014124A (en) Aptamer preparation.
MX2014013083A (en) Injectable pharmaceutical composition of dexketoprofen and tramadol.
PH12017501005A1 (en) Injectable formulations of paracetamol
MX2015010517A (en) Etanercept composition having improved stability.
MX2015013160A (en) Method and products for enhancing cellular uptake of drug and dietary supplements.
GEP20196947B (en) Bremelanotide therapy for female sexual dysfunction
Jianlan Addressing Sustainability via AI-Report from the 23rd International Joint Conference on Artificial Intelligence
IL283041A (en) Needleless epidermal syringe for needle-free injection of active ingredient-containing solution
UA111785C2 (en) A COMPOSITION FOR THE TREATMENT OF Warts And A WAY OF TREATMENT
UA74097U (en) Method for manufacturing drug for treatment of tuberculosis
EA201800360A1 (en) METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION CONTAINING BENDAMUSTINE, PHARMACEUTICAL COMPOSITION OF BENDAMUSTIN
PL414785A1 (en) 3-dodecylsulfanyl-butyric acid to be used as a medicine, preferably to prevent development of insulin immunity and the composition containing 3-dodecylsulfanyl-butyric acid as active substance
PL404002A1 (en) Pharmaceutical composition in the form of an aerosol and the method of preparing the pharmaceutical composition
IN2013MU03613A (en)
UA99921U (en) Method of controlled sedation in patients with alcohol withdrawal condition in the intensive care
UA83813U (en) Method for treating neurosyphilis with mesenchymal alterations

Legal Events

Date Code Title Description
HC1A Change in name of an applicant in a eurasian application
TH4A Publication of the corrected specification to eurasian patent
QB4A Registration of a licence in a contracting state